Skip to main content

C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo.

Publication ,  Journal Article
Clough, B; Finethy, R; Khan, RT; Fisch, D; Jordan, S; Patel, H; Coers, J; Frickel, E-M
Published in: Wellcome Open Res
2019

Background: Infections cause the production of inflammatory cytokines such as Interferon gamma (IFNγ). IFNγ in turn prompts the upregulation of a range of host defence proteins including members of the family of guanylate binding proteins (Gbps). In humans and mice alike, GBPs restrict the intracellular replication of invasive microbes and promote inflammation. To study the physiological functions of Gbp family members, the most commonly chosen in vivo models are mice harbouring loss-of-function mutations in either individual Gbp genes or the entire Gbp gene cluster on mouse chromosome 3. Individual Gbp deletion strains differ in their design, as some strains exist on a pure C57BL/6 genetic background, while other strains contain a 129-derived genetic interval encompassing the Gbp gene cluster on an otherwise C57BL/6 genetic background. Methods: To determine whether the presence of 129 alleles of paralogous Gbps could influence the phenotypes of 129-congenic Gbp-deficient strains, we studied the expression of Gbps in both C57BL/6J and 129/Sv mice following in vivo stimulation with adjuvants and after infection with either Toxoplasma gondii or Shigella flexneri. Results: We show that C57BL/6J relative to 129/Sv mice display moderately elevated expression of Gbp2, but more prominently, are also defective for Gbp2b (formerly Gbp1) mRNA induction upon immune priming. Notably, Toxoplasma infections induce robust Gbp2b protein expression in both strains of mice, suggestive of a Toxoplasma-activated mechanism driving Gbp2b protein translation. We further find that the higher expression of Gbp2b mRNA in 129/Sv mice correlates with a gene duplication event at the Gbp2b locus resulting in two copies of the Gbp2b gene on the haploid genome of the 129/Sv strain. Conclusions: Our findings demonstrate functional differences between 129 and C57BL/6 Gbp alleles which need to be considered in the design and interpretation of studies utilizing mouse models, particularly for phenotypes influenced by Gbp2 or Gbp2b expression.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Wellcome Open Res

DOI

ISSN

2398-502X

Publication Date

2019

Volume

4

Start / End Page

124

Location

England

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clough, B., Finethy, R., Khan, R. T., Fisch, D., Jordan, S., Patel, H., … Frickel, E.-M. (2019). C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo. Wellcome Open Res, 4, 124. https://doi.org/10.12688/wellcomeopenres.15329.1
Clough, Barbara, Ryan Finethy, Rabia T. Khan, Daniel Fisch, Sarah Jordan, Harshil Patel, Jörn Coers, and Eva-Maria Frickel. “C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo.Wellcome Open Res 4 (2019): 124. https://doi.org/10.12688/wellcomeopenres.15329.1.
Clough B, Finethy R, Khan RT, Fisch D, Jordan S, Patel H, et al. C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo. Wellcome Open Res. 2019;4:124.
Clough, Barbara, et al. “C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo.Wellcome Open Res, vol. 4, 2019, p. 124. Pubmed, doi:10.12688/wellcomeopenres.15329.1.
Clough B, Finethy R, Khan RT, Fisch D, Jordan S, Patel H, Coers J, Frickel E-M. C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo. Wellcome Open Res. 2019;4:124.

Published In

Wellcome Open Res

DOI

ISSN

2398-502X

Publication Date

2019

Volume

4

Start / End Page

124

Location

England

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences